Yıl: 2023 Cilt: 10 Sayı: 1 Sayfa Aralığı: 67 - 73 Metin Dili: İngilizce DOI: 10.14744/nci.2021.00018 İndeks Tarihi: 03-05-2023

Relationship of HLA-B alleles on susceptibility to and protection from HIV infection in Turkish population

Öz:
OBJECTIVE: Many human leukocyte antigen (HLA)-B alleles are associated with an increased risk of Acquired Immune Defi ciency Syndrome (AIDS) and Human Immunodeficiency Virus (HIV) progression; however, their distribution varies among dif ferent racial/ethnic groups. Abacavir used in the treatment of AIDS significantly increases the risk of hypersensitivity reactions in patients with HLA-B*57:01. The aim of this study was to determine the distribution of HIV-associated HLA-B subgroups (high and low resolution) and HLA-B*57:01 associated with Abacavir sensitivity in Turkiye. METHODS: This retrospective case-control study consisted of 416 (F/M:111/305) HIV positive patients and 416 (F/M:111/305) healthy controls. HLA-B alleles were identified using Luminex based low-resolution method and further subgrouped by se quence-based high-resolution typing. RESULTS: Our data showed that in patients with HIV-1 infection, HLA-B*15, *35, and *51 allele frequencies were high er, while the HLA-B*07, *14 and *55 allele frequencies were lower as compared to the controls. It was determined that HLA-B*15:01, *35:01, *35:08, and *51:01 alleles frequencies were higher in the patients with HIV-1 infection compared to the controls as HLA-B*07:02, *14:01, *44:01, and *55:01 allele frequencies were detected low. HLA-B*57:01 allele positivity, which is important in Abacavir hypersensitivity, was lower than controls, and this difference was not statistically significant. CONCLUSION: Our results suggest that, HLA-B*07, *14, and *55 alleles and HLA-B*07:02, *14:01, *44:01, and *55:01 subgroups might have a protective effect, while HLA-B*15, *35, and *51 alleles and HLA-B*15:01, *35:01, *35:08, and *51:01 subgroups might play a role in susceptibility to HIV-1 infection.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Gallo RC, Montagnier L. The discovery of HIV as the cause of AIDS. N Engl J Med 2003;349:2283–5.
  • 2. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Sat ten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853–60.
  • 3. Brennan CA, Ibarrondo FJ, Sugar CA, Hausner MA, Shih R, Ng HL, et al. Early HLA-B*57-restricted CD8+ T lymphocyte responses pre dict HIV-1 disease progression. J Virol 2012;86:10505–16.
  • 4. Goulder PJ, Walker BD. HIV and HLA class I: an evolving relation ship. Immunity 2012;37:426–40.
  • 5. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L, et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonpro gressors. Proc Natl Acad Sci U S A 2000;97:2709–14.
  • 6. Pereyra F, Addo MM, Kaufmann DE, Liu Y, Miura T, Rathod A, et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis 2008;197:563– 71.
  • 7. Uçar F, Karkucak M, Alemdaroğlu E, Capkin E, Yücel B, Sönmez M, et al. HLA-DRB1 allele distribution and its relation to rheuma toid arthritis in eastern Black Sea Turkish population. Rheumatol Int 2012;32:1003–7.
  • 8. Uçar F, Sönmez M, Ermantaş N, Özbaş HM, Cansız A, Balcı M, et al. The associations of HLA-A, -B, DRB1 alleles and haplotypes in Turk ish lymphoma patients. Gene 2016;586:263–7.
  • 9. Mondal MN, Shitan M. Factors affecting the HIV/AIDS epidemic: an ecological analysis of global data. Afr Health Sci 2013;13:301–10.
  • 10. Muula AS. HIV infection and AIDS among young women in South Africa. Croat Med J 2008;49:423–35.
  • 11. Rizvi SM, Salam N, Geng J, Qi Y, Bream JH, Duggal P, et al. Distinct assembly profiles of HLA-B molecules. J Immunol 2014;192:4967–76.
  • 12. Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, Chet ty S, et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004;432:769–75.
  • 13. de Sorrentino AH, Marinic K, Motta P, Sorrentino A, López R, Illio vich E. HLA class I alleles associated with susceptibility or resistance to human immunodeficiency virus type 1 infection among a population in Chaco Province, Argentina. J Infect Dis 2000;182:1523–6.
  • 14. Fabio G, Scorza R, Lazzarin A, Marchini M, Zarantonello M, D’Ar minio A, et al. HLA-associated susceptibility to HIV-1 infection. Clin Exp Immunol 1992;87:20–3.
  • 15. Fabio G, Smeraldi RS, Gringeri A, Marchini M, Bonara P, Mannucci PM. Susceptibility to HIV infection and AIDS in Italian haemophili acs is HLA associated. Br J Haematol 1990;75:531–6.
  • 16. Hendel H, Caillat-Zucman S, Lebuanec H, Carrington M, O’Brien S, Andrieu JM, et al. New class I and II HLA alleles strongly asso ciated with opposite patterns of progression to AIDS. J Immunol 1999;162:6942–6.
  • 17. Kaslow RA, Carrington M, Apple R, Park L, Muñoz A, Saah AJ, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996;2:405–11.
  • 18. Inan D, Sayan M. Molecular epidemiology of HIV-1 strains in Antalya, Turkey. J Int AIDS Soc 2014;17:19684.
  • 19. Deveci A, Coban AY, Durupınar B. Prevalence of human leukocyte antigen (HLA)-B* 57: 01 in HIV-infected patients. Mikrobiyoloji Bul 2016;50:544–51.
  • 20. Inan D, Sayan M, Deveci A, Uçar F. HLA-B* 57: 01 HLA-B 57:01 allele prevalence in Turkish HIV infected patients and the value of real time PCR allele testing compared with sequence specific primer tech nique. Journal of the International AIDS Society 2018;21:e25187.
  • 21. Uçar F, Çapkin E, Karkucak M, Yücel B, Sönmez M, Alver A, et al. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey. Int J Rheum Dis 2012;15:538–45.
  • 22. Uçar F, Sönmez M, Erkut N, Balcı M, Yücel B, Yılmaz M, et al. Relation of HLA-A, -B, -DRB1 alleles and haplotypes in patients with acute leukemia: a case control study. Arch Med Res 2011;42:305–10.
  • 23. World Health Organization. Global HIV Programme. World Health Organization Web site. Available at: http://www.who.int/teams/ global-hiv-hepatitis-and-stis-programmes/hiv/strategic-information/ hiv-data-and-statistics. Accessed Mar 23, 2021.
  • 24. Johnson L, Budlender D. Johnson, L. and D. Budlender, CARE Mono graph No. 8. 2002, Centre for Actuarial Research, University of Cape Town Cape Town. Centre for Actuarial Research (CARE): Care Monograph No. 8; 2022.
  • 25. Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1995;1:59–64.
  • 26. International HIV Controllers Study, Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, et al M. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010;330:1551–7.
  • 27. Winchester R, Pitt J, Charurat M, Magder LS, Göring HH, Landay A, et al. Mother-to-child transmission of HIV-1: strong association with certain maternal HLA-B alleles independent of viral load im plicates innate immune mechanisms. J Acquir Immune Defic Syndr 2004;36:659–70.
  • 28. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999;283:1748–52.
  • 29. Carlson JM, Listgarten J, Pfeifer N, Tan V, Kadie C, Walker BD, et al. Widespread impact of HLA restriction on immune control and escape pathways of HIV-1. J Virol 2012;86:5230–43.
  • 30. Mori M, Wichukchinda N, Miyahara R, Rojanawiwat A, Pathipvanich P, Maekawa T, et al. HLA-B*35: 05 is a protective allele with a unique structure among HIV-1 CRF01_AE-infected Thais, in whom the B*57 frequency is low. AIDS 2014;28:959–67.
  • 31. Leslie A, Matthews PC, Listgarten J, Carlson JM, Kadie C, Ndung’u T, et al. Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. J Virol 2010;84:9879–88.
  • 32. Small CB, Margolis DA, Shaefer MS, Ross LL. HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensi tivity reaction in HLA-B*57:01-negative subjects. BMC Infect Dis 2017;17:256.
  • 33. Orkin C, Sadiq ST, Rice L, Jackson F; UK EPI team. Prospective epidemiological study of the prevalence of human leukocyte anti gen (HLA)-B*5701 in HIV-1-infected UK subjects. HIV Med 2010;11:187–92.
  • 34. Zhang H, Zhang T, Zhao H, Han N, Zhou H, He Y, et al. Low preva lence of human leukocyte antigen-B*5701 in HIV-1-infected Chinese subjects: a prospective epidemiological investigation. AIDS Res Ther 2015;12:28.
APA Darbas S, KILINÇ Y, Arslan H, İNAN D, UÇAR F, boylubay ö, KOKSOY S, Mutlu E, YUCEL B, Sayın EKİNCİ N (2023). Relationship of HLA-B alleles on susceptibility to and protection from HIV infection in Turkish population. , 67 - 73. 10.14744/nci.2021.00018
Chicago Darbas Sule,KILINÇ YAHYA,Arslan Habibe Sema,İNAN DİLARA,UÇAR Fahri,boylubay özaydın,KOKSOY SADI,Mutlu Esvet,YUCEL Burcu,Sayın EKİNCİ Nurten Relationship of HLA-B alleles on susceptibility to and protection from HIV infection in Turkish population. (2023): 67 - 73. 10.14744/nci.2021.00018
MLA Darbas Sule,KILINÇ YAHYA,Arslan Habibe Sema,İNAN DİLARA,UÇAR Fahri,boylubay özaydın,KOKSOY SADI,Mutlu Esvet,YUCEL Burcu,Sayın EKİNCİ Nurten Relationship of HLA-B alleles on susceptibility to and protection from HIV infection in Turkish population. , 2023, ss.67 - 73. 10.14744/nci.2021.00018
AMA Darbas S,KILINÇ Y,Arslan H,İNAN D,UÇAR F,boylubay ö,KOKSOY S,Mutlu E,YUCEL B,Sayın EKİNCİ N Relationship of HLA-B alleles on susceptibility to and protection from HIV infection in Turkish population. . 2023; 67 - 73. 10.14744/nci.2021.00018
Vancouver Darbas S,KILINÇ Y,Arslan H,İNAN D,UÇAR F,boylubay ö,KOKSOY S,Mutlu E,YUCEL B,Sayın EKİNCİ N Relationship of HLA-B alleles on susceptibility to and protection from HIV infection in Turkish population. . 2023; 67 - 73. 10.14744/nci.2021.00018
IEEE Darbas S,KILINÇ Y,Arslan H,İNAN D,UÇAR F,boylubay ö,KOKSOY S,Mutlu E,YUCEL B,Sayın EKİNCİ N "Relationship of HLA-B alleles on susceptibility to and protection from HIV infection in Turkish population." , ss.67 - 73, 2023. 10.14744/nci.2021.00018
ISNAD Darbas, Sule vd. "Relationship of HLA-B alleles on susceptibility to and protection from HIV infection in Turkish population". (2023), 67-73. https://doi.org/10.14744/nci.2021.00018
APA Darbas S, KILINÇ Y, Arslan H, İNAN D, UÇAR F, boylubay ö, KOKSOY S, Mutlu E, YUCEL B, Sayın EKİNCİ N (2023). Relationship of HLA-B alleles on susceptibility to and protection from HIV infection in Turkish population. İstanbul Kuzey Klinikleri, 10(1), 67 - 73. 10.14744/nci.2021.00018
Chicago Darbas Sule,KILINÇ YAHYA,Arslan Habibe Sema,İNAN DİLARA,UÇAR Fahri,boylubay özaydın,KOKSOY SADI,Mutlu Esvet,YUCEL Burcu,Sayın EKİNCİ Nurten Relationship of HLA-B alleles on susceptibility to and protection from HIV infection in Turkish population. İstanbul Kuzey Klinikleri 10, no.1 (2023): 67 - 73. 10.14744/nci.2021.00018
MLA Darbas Sule,KILINÇ YAHYA,Arslan Habibe Sema,İNAN DİLARA,UÇAR Fahri,boylubay özaydın,KOKSOY SADI,Mutlu Esvet,YUCEL Burcu,Sayın EKİNCİ Nurten Relationship of HLA-B alleles on susceptibility to and protection from HIV infection in Turkish population. İstanbul Kuzey Klinikleri, vol.10, no.1, 2023, ss.67 - 73. 10.14744/nci.2021.00018
AMA Darbas S,KILINÇ Y,Arslan H,İNAN D,UÇAR F,boylubay ö,KOKSOY S,Mutlu E,YUCEL B,Sayın EKİNCİ N Relationship of HLA-B alleles on susceptibility to and protection from HIV infection in Turkish population. İstanbul Kuzey Klinikleri. 2023; 10(1): 67 - 73. 10.14744/nci.2021.00018
Vancouver Darbas S,KILINÇ Y,Arslan H,İNAN D,UÇAR F,boylubay ö,KOKSOY S,Mutlu E,YUCEL B,Sayın EKİNCİ N Relationship of HLA-B alleles on susceptibility to and protection from HIV infection in Turkish population. İstanbul Kuzey Klinikleri. 2023; 10(1): 67 - 73. 10.14744/nci.2021.00018
IEEE Darbas S,KILINÇ Y,Arslan H,İNAN D,UÇAR F,boylubay ö,KOKSOY S,Mutlu E,YUCEL B,Sayın EKİNCİ N "Relationship of HLA-B alleles on susceptibility to and protection from HIV infection in Turkish population." İstanbul Kuzey Klinikleri, 10, ss.67 - 73, 2023. 10.14744/nci.2021.00018
ISNAD Darbas, Sule vd. "Relationship of HLA-B alleles on susceptibility to and protection from HIV infection in Turkish population". İstanbul Kuzey Klinikleri 10/1 (2023), 67-73. https://doi.org/10.14744/nci.2021.00018